|
|
||
|
Clinical Impact of High-Normal Blood Pressure High-normal blood pressure is associated with an increased risk of cardiovascular events. It remains to be shown whether treating blood pressure in the high-normal range can reduce this risk. |
||
|
Fondaparinux versus Enoxaparin to Prevent Venous Thromboembolism after Hip-Fracture Surgery
Venous thromboembolism after surgery for hip fracture is a troublesome problem, and its incidence is high (10 to 20 percent) even with the use of low-molecular-weight heparin for thromboprophylaxis. The promising results with fondaparinux, a new synthetic pentasaccharide that causes selective inhibition of activated factor X, in preventing venous thromboembolism after surgery for hip fracture merit wide attention. |
||
|
Fondaparinux versus Enoxaparin to Prevent Venous Thromboembolism after Major Knee Surgery
Fondaparinux is a synthetic anticoagulant that binds to antithrombin, thereby causing it rapidly to inactivate activated factor X (factor Xa), an indispensable coagulant protein. The finding of its superiority over enoxaparin in patients undergoing knee surgery is important, because postoperative venous thromboembolism has been difficult to prevent after this operation. |
||
|
Effects of Eliminating Gatekeeping in a Health Maintenance Organization
These findings suggest that the use of gatekeeping to limit access to specialists may have a smaller effect on health care costs than previously thought. However, the study was conducted in one group-model health maintenance organization; the results may not be generalizable to other health plans. |
||
|
Medical Progress: Infective Endocarditis in Adults
|
||
|
Advances in Immunology: Maternal Antibodies, Childhood Infections, and Autoimmune Diseases
|
||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |